The AMR Narrative

Bacteria and Antibiotic Resistance: A Strategy of Self-Defense

Antimicrobial resistance (AMR) is a very complex topic, rather tough to explain. It involves the ability of microorganisms, such as bacteria, to resist the effects of antimicrobial medicines, including antibiotics, which are used to treat infections. For this reason, there are several common misconceptions, myths and false perceptions around this subject.

For example, have you ever heard someone say: “I am resistant to this antibiotic”? Well, this sentence is wrong. Indeed, contrary to common belief, antibiotic resistance is not about the human body becoming resistant to antibiotics.

It is actually the bacteria themselves that develop resistance to these medicines, a self-defence to prevent antibiotics from harming them. As a result, antibiotics – used by doctors and veterinarians – become less and less effective or even completely ineffective in treating bacterial infections.

In this blog I will describe to you in a simple way how bacteria become resistant to antibiotics.
Let me start with a few important basics. A bacterium is a microscopic organism made up of a simple, single cell. Outside, it has two different protective coverings: a capsule and a cell wall. Inside the cell, the DNA is loose in a gooey substance (called cytoplasm). The cytoplasm surrounds a number of small but essential structures (e.g., the ribosomes) that enable the bacterial cell to survive and multiply.

Antibiotics disrupt these structures and block the functioning of vital processes, either killing or stopping bacteria from multiplying. Therefore, to protect themselves against the actions of these medicines, these microorganisms have developed different and effective defence mechanisms.

(A tip: try to imagine the antibiotic as a key, and the bacterial structures it specifically targets as a lock: it will be easier to understand what I am going to describe.)

  • Modifying the antibiotic
    Bacteria can produce substances (called enzymes) that can change the chemical structure of the antibiotic. This prevents the antibiotic from binding to its target inside the cell. A different key cannot open the same lock, unfortunately.

  • Destroying the antibiotic
    In this case, bacteria produce enzymes that destroy and inactivate the antibiotic. An example is the so-called enzyme beta-lactamase, which breaks apart the beta-lactam ring of penicillins. As you can easily guess, a broken key does not open the lock.

  • Keeping the antibiotic out of the cell
    Bacteria are able to change the structure of their cell wall, making it more difficult for the antibiotic to pass through or even blocking it from entering the cell. In this case, the key is available and can open the lock, but it is too far.

  • Pumping the antibiotic out if it gets in
    Bacteria can insert actual “pumps” into their cell wall, capable of expelling unwanted substances out of the cell (including antibiotics). Moreover, bacteria can even produce multiple pumps. In this case, the lock is very close, but suddenly the key flies away.

  • Disguising the target of the antibiotic
    Finally, bacteria can change their own structure (the target), thus preventing the antibiotic from interacting with it and protecting it from being irreparably damaged. The lock has been changed and the key is no longer able to open it. What a pity!

These tiny organisms have developed truly fascinating and effective ways to survive, haven’t they? Here are the secrets of their billions of years of evolution!

And imagine: every day scientists learn something new about the resistance mechanisms of microorganisms.

Now you know and understand that it is not the human body that becomes resistant to antibiotics. Rather, bacteria are able to develop resistance to overcome repeated antibiotic attacks.

As I said: it is a matter of self-defence for them.

Francesco M. Labricciosa

Francesco M. Labricciosa is a Medical Doctor from Italy. After earning a post-graduate diploma in Primary Care Medicine, he consolidated his experience in different healthcare settings, and then became a specialist in Hygiene and Preventive Medicine.

Antimicrobial Resistance (AMR), optimal and prudent use of antimicrobials, and awareness towards consumption of these medications represent his main fields of interest.

Since 2016, he has been working with the Global Alliance for Infections in Surgery. He participated in several international research projects about prevention and management of healthcare-associated infections, surgical antibiotic prophylaxis, antimicrobial therapy in intra-abdominal infections, and antimicrobial stewardship programs. He has co-authored more than 40 articles published in peer-reviewed medical journals.

In 2023 he started an interesting collaboration with The AMR Narrative, serving as an Independent Advisor for the charity, and writing blogs to promote public understanding and education for AMR.

Moreover, Francesco works with several medical communication agencies in designing and finalising educational materials aimed at diversified audiences. Finally, he takes an active role in science communication blogging about antimicrobial use and AMR.

Chris Shaffer

Chris Shaffer was a music, special education teacher, and high school principal for 45 years. At the end of his educational career, he was thrust into the world of AMR infections when a number of abdominal surgeries left him with an E-coli infection which failed to respond to antibiotics. After doctors in the USA left him with little hope for a cure, diminishing health, and a bleak prognosis, he set out on his own.

Chris found success in phage therapy at the Eliava Phage Therapy Center in Tbilisi, Georgia. With phage therapy giving Chris his life back, he has dedicated his retirement years to advocating for and helping raise awareness of phage therapy used for AMR infections. He tells the story of his phage journey in a book titled, Finding Phage: How I Partnered with a Friendly Virus to Cure My Deadly Bacterial Superinfection. His website, phagetherpyusa.com helps others learn to understand the healing power of phage therapy.

Demi Christofi

Demi is an Associate Scientific Director at a medical communications agency, with a background in microbiology and a longstanding focus on antimicrobial resistance. She holds an MSc in Microbiology, where she first became interested in the global challenge of resistance and the need to bring scientific understanding to wider audiences.

Demi’s career has centred on a simple but powerful belief: that how we communicate science matters. Her work focuses on making complex data clear, engaging, and accessible – whether for healthcare professionals, policy makers, or the patients most affected by infection and resistance. She has contributed to a wide range of AMR-focused projects, including educational programmes, congress communications and stewardship initiatives.

A central thread in Demi’s work is the importance of the patient voice. She is passionate about making sure real-world experiences of treatment failure, recurrent infections, and the anxiety surrounding resistance are not lost in the data. She believes that listening to patients and involving them meaningfully is essential for shaping more effective, human-centred responses to AMR.

Demi is also a strong advocate of the One Health approach, recognising AMR as a complex, interconnected issue that spans human health, animal health, and the environment. She is particularly drawn to efforts that move beyond siloed thinking and focus on practical, joined-up solutions.

In 2025, Demi joined The AMR Narrative as an Independent Advisor, where she supports the charity’s mission to centre communication, community, and inclusion in the global AMR response.

Outside of work, she is a Girlguiding unit leader and a qualified yoga teacher. These roles reflect her commitment to care, learning, and creating supportive spaces for others.

Andrea Hartley

Andrea has worked in health communications and campaigning for 3 decades. She is committed to fighting AMR through timely and appropriate communications globally,.

Andrea set up Skating Panda, the creative social and environmental impact consultancy, over a decade ago and drives its impact and growth. Focused on original and lasting public interest communications as well as issue strategy and advocacy, the Panda team has a track record of prompting tipping points in the status quo that drive better social and planetary outcomes.

Andrea’s combination of commercial marketing and development experience with deep issue knowledge have been sought by decision-makers at global summits, corporate and NGO board members, and have enabled her to set up multi-million fundraising platforms and push through policies that change and save lives. 

Andrea is Vice Chair of mothers2mothers, the world’s largest employer of women living with HIV, and a Board Director of Maymessy, a food poverty social enterprise.

A lifelong advocate for gender equality, she played a key role in establishing the UK’s Women’s Equality Party.

Esmita Charani

Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.

She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.